46 results on '"Seyler, Lucie"'
Search Results
2. A cross-sectional case–control study on the structural connectome in recovered hospitalized COVID-19 patients
3. A public health value-based healthcare paradigm for HIV
4. Antibiotic Prescriptions Targeting Bacterial Respiratory Infections in Admitted Patients with COVID-19: A Prospective Observational Study
5. Genomic monitoring of SARS‐CoV‐2 variants using sentinel SARI hospital surveillance
6. A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial
7. Correction to: A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial
8. Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.
9. Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID- 19 and VEBIS SARI VE networks, Europe, 2021 to 2022.
10. Surfing the Waves: Differences in Hospitalised COVID-19 Patients across 4 Variant Waves in a Belgian University Hospital
11. Severity of COVID-19 among Hospitalized Patients: Omicron Remains a Severe Threat for Immunocompromised Hosts
12. Population pharmacokinetics and dosing simulations of cefepime in septic shock patients receiving continuous renal replacement therapy
13. Healthcare-Associated COVID-19 across Five Pandemic Waves: Prediction Models and Genomic Analyses
14. Early high antibody titre convalescent plasma for hospitalised COVID-19 patients: DAWn-plasma
15. Rapid quantification of six β-lactams to optimize dosage regimens in severely septic patients
16. Healthcare-associated COVID-19 across 3 pandemic waves: patient characterisation and validation of clinical definitions using genome sequencing
17. Troponin T in COVID-19 hospitalized patients: Kinetics matter
18. Presumed Urinary Tract Infection in Patients Admitted with COVID-19: Are We Treating Too Much?
19. Establishing a novel European hospital surveillance platform in response to a newly emerging infection lessons from the I-MOVE-COVID-19 hospital network
20. Enhanced surveillance of COVID-19 in secondary care in Europe: a tale of two waves
21. Early high antibody titre convalescent plasma for hospitalised COVID-19 patients: DAWn-plasma
22. A Public Health Value-Based Healthcare Paradigm for HIV
23. Belgian twins born with the Gamma variant of SARS-CoV-2: Transplacental versus intrapartum transmission?
24. Additional file 4 of A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial
25. Additional file 3 of A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial
26. Additional file 2 of A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial
27. Additional file 1 of A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial
28. A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial.
29. Outpatient parenteral antibiotic therapy for the treatment of prosthetic knee and hip infections in Belgium, a cost minimization analysis.
30. Outpatient parenteral antibiotic therapy for the treatment of prosthetic knee and hip infections in Belgium, a cost minimization analysis
31. Pathologies hématologiques liées à l'infection par le VIH
32. Current challenges in the treatment of HIV
33. Under the water: skin and soft tissue infections with an atypical cause
34. Pyomyositis secondary to a community-associated methicillin-resistant Staphylococcus aureus prostatic abscess
35. Haemophagocytic Syndrome in a 19-Year-Old Male with Plasmodium falciparum Malaria
36. β-lactam antibiotic concentrations during continuous renal replacement therapy
37. Case-Control Study of Drug Monitoring of β-Lactams in Obese Critically Ill Patients
38. Reactive Arthritis due toShigellaInfection after a Visit to Egypt: A Late Complication of an Intestinal Infection
39. Recommended β-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy
40. Case-Control Study of Drug Monitoring of β-Lactams in Obese Critically Ill Patients
41. Reactive Arthritis due to Shigella Infection after a Visit to Egypt: A Late Complication of an Intestinal Infection.
42. Severity of COVID-19 among Hospitalized Patients: Omicron Remains a Severe Threat for Immunocompromised Hosts
43. Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022.
44. Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.
45. Early high antibody titre convalescent plasma for hospitalised COVID-19 patients: DAWn-plasma.
46. Belgian twins born with the Gamma variant of SARS-CoV-2: Transplacental versus intrapartum transmission?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.